One lot of Xanax recalled nationwide over quality issue, FDA says
medicalxpress - A widely used anxiety medication is being pulled from shelves due to "failed dissolution specifications," the U.S. Food and Drug Administration (FDA) said.
AI Summary: Regulators have flagged a quality issue and a manufacturer has recalled a specific lot of Xanax nationwide. Pharmacies and patients have been advised to check lot numbers and return affected pills; health officials emphasize the recall is precautionary, urging anyone with concerns to consult their pharmacist or clinician rather than panic-buy substitutes.
Related Stories
FDA Approves Immunotherapy Combo for Bladder Cancer / 7 months
FDA to Remove Black Box Warnings from Menopausal Hormone Therapies / 7 months
FDA clears first new sunscreen ingredient in two decades / 28 days
FDA commissioner Marty Makary resigns amid mounting scrutiny / 1 month
RFK Jr launches plan to curb antidepressant overprescription / 2 months
FDA Lifts Hold on Intellia’s Phase 3 Gene Editing Trial / 5 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Healthcare, Eli Lilly, Medicare Advantage (not listed), Cybersecurity and look for the RSS link.
StackHealth Time Machine